Symbol="SGMO"
AssetType="Common Stock"
Name="Sangamo Therapeutics Inc"
Description="Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic drugs that transform the lives of patients using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company is headquartered in Brisbane, California."
CIK="1001233"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="501 CANAL BLVD, POINT RICHMOND TECH CNTR., RICHMOND, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="230247000"
EBITDA="-66650000"
PERatio="None"
PEGRatio="0"
BookValue="1.954"
DividendPerShare="0"
DividendYield="0"
EPS="-0.79"
RevenuePerShareTTM="1.507"
ProfitMargin="-0.528"
OperatingMarginTTM="-0.33"
ReturnOnAssetsTTM="-0.0907"
ReturnOnEquityTTM="-0.38"
RevenueTTM="241025000"
GrossProfitTTM="-138599000"
DilutedEPSTTM="-0.79"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.595"
AnalystTargetPrice="7.38"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="4.826"
PriceToBookRatio="1.829"
EVToRevenue="2.602"
EVToEBITDA="-1.758"
Beta="1.113"
num_52WeekHigh="6.42"
num_52WeekLow="1.07"
num_50DayMovingAverage="1.284"
num_200DayMovingAverage="2.548"
SharesOutstanding="171826000"
DividendDate="None"
ExDividendDate="None"
symbol="SGMO"
open="1.36"
high="1.36"
low="1.32"
price="1.34"
volume="688999.00"
latest_trading_day="2023-07-26"
previous_close="1.35"
change="-0.01"
change_percent="-0.7407%"
aroon_positive_momentum_days="1"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="TRUE"
Aroon_momentum="1"
Volume_recent_avg="2439455"
Change_recent_avg="-0.02"
Delta_recent_avg="0.12"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.93"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="positive"
Aroon_change="TRUE"
Aroon_momentum_positive="1"
Aroon_momentum_negative="99"
image_negative_thumbnail_id_1="146"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0030.jpeg"
image_negative_thumbnail_id_2="165"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0011.jpeg"
image_neutral_thumbnail_id_1="574"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_neutral_thumbnail_id_2="578"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0021.jpeg"
image_positive_thumbnail_id_1="690"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0018.jpeg"
image_positive_thumbnail_id_2="949"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0111.jpeg"
image_professor_thumbnail_id_1="1197"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
